StockNews.AI
QTI
StockNews.AI
218 days

QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth

1. QT Imaging plans to enhance finances by managing liabilities effectively. 2. Company forecasts revenues of $18M in 2025 and $27M in 2026. 3. Amendments to debts extend maturity to March 31, 2026, with no payments due. 4. QTI aims to deliver 40 scanners in 2025 and 60 in 2026. 5. Strong growth anticipated signals a positive outlook for the company's future.

Earnings
+1.36%Current Return
VS
-0.08%S&P 500
$0.45501/13 08:42 AM EDTEvent Start
$0.461201/14 03:19 PM EDTLatest Updated
6m saved
Insight
Article

FAQ

Why Bullish?

Forecasted revenue growth and debt restructuring may improve investor confidence.

How important is it?

The article directly addresses QTI's financial strategies and future growth potential.

Why Long Term?

Positive revenue projections indicate sustained performance beyond immediate future, similar to past growth trends.

Related Companies

QTI
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) (the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce strengthening of its financials, by clearing its short-term liabilities and by forecasting solid revenue growth in 2025 and 2026. The Company announced amendments to both its convertible promissory note with YA II PN, Ltd. (the “YA Investor,” and such promissory note, the “YA Note”) and to its convertible promissory note with Funicular Funds, LP (the “Cable Car Investor,” and such promissory note, the “Cable Car Note”), each of which was entered into on January 9, 2025. With the amendments of YA Note and Cable Car Note, both notes are maturing on March 31, 2026, by which date the outstanding principal balance and the annual interest of 6% are due. No payments whatsoever are to be made by the Company till that date. Comprehensive details of both agreements are included in the Form 8-K filed by the Company with the SEC on January 10, 2025. Additionally, the Company forecasts revenue of $18M in 2025 and $27M in 2026, a significant increase from 2024 revenue. “On behalf of the QTI leadership team and Board of Directors, I would like to thank the YA Investor and Cable Car Investor teams for their partnership and trust, as the execution of these amendments gives the QTI team the runway to successfully execute on our quarterly plan to deliver a minimum of 40 scanners in 2025, and 60 scanners in 2026, for a total of $45M in revenue for both years,” said Dr. Raluca Dinu, Chief Executive Officer. About QT Imaging Holding, Inc. QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com. Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding future payments by QT Imaging Holdings under the YA Note and the Cable Car Note, plans for QT Imaging Holdings, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the Breast Acoustic CT™ Scanner, the ability of QT Imaging Holdings to sell and deploy the Breast Acoustic CT™ Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging Holding’s (and its predecessor, GigCapital5, Inc.) filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.

Related News